
A cohort of zzso arthritis zzso patients in the zzso zzso Network zzso registry and receiving zzso therapy was evaluated after 6, 12, 24, and 36 zzso Of the zzso patients in the registry zzso met the clinical criteria for inclusion with zzso receiving zzso zzso zzso and 242 zzso The therapeutic survival curve of these patients showed that the likelihood of continuing zzso therapy was zzso after 12 months, zzso after 24 months, and zzso after 36 months, with a risk of dropout similar for zzso and adverse zzso There were 405 zzso therapy zzso zzso 180 zzso due to zzso zzso zzso adverse events, and 31 zzso other zzso Four deaths (2 zzso 1 zzso zzso 1 heart zzso were considered to be related to zzso zzso Of the zzso 219 zzso occurred within the first 12 zzso 110 due to adverse events, 89 zzso and 20 due to other zzso After 36 months, the likelihood of survival on zzso zzso was significantly greater than the likelihood of survival on zzso zzso or zzso zzso A higher risk of therapy zzso due to adverse events was associated with increasing age, a zzso zzso 5 zzso a high zzso zzso rate zzso a higher risk of therapy zzso due to zzso was associated with the previous use of zzso or zzso 4 zzso zzso drugs zzso and a high zzso zzso increasing zzso values and zzso with zzso were associated with a lower risk of zzso 

